Welcome to LookChem.com Sign In|Join Free
  • or
3-(benzyloxy)naphthalen-2-amine is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

1092455-29-2

Post Buying Request

1092455-29-2 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1092455-29-2 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 1092455-29-2 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,0,9,2,4,5 and 5 respectively; the second part has 2 digits, 2 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 1092455-29:
(9*1)+(8*0)+(7*9)+(6*2)+(5*4)+(4*5)+(3*5)+(2*2)+(1*9)=152
152 % 10 = 2
So 1092455-29-2 is a valid CAS Registry Number.

1092455-29-2Relevant academic research and scientific papers

Enantioselective Synthesis of 3,3′-Disubstituted 2-Amino-2′-hydroxy-1,1′-binaphthyls by Copper-Catalyzed Aerobic Oxidative Cross-Coupling

Zhao, Xiao-Jing,Li, Zi-Hao,Ding, Tong-Mei,Tian, Jin-Miao,Tu, Yong-Qiang,Wang, Ai-Fang,Xie, Yu-Yang

supporting information, p. 7061 - 7065 (2021/02/27)

A challenging direct asymmetric catalytic aerobic oxidative cross-coupling of 2-naphthylamine and 2-naphthol, using a novel CuI/SPDO system, has been successfully developed for the first time. Enantioenriched 3,3′-disubstituted NOBINs were achieved and could be readily derived to divergent chiral ligands and catalysts. This reaction features high enantioselectivities (up to 96 % ee) and good yields (up to 80 %). The DFT calculations suggest that the F–H interactions between CF3 of L17 and H-1,8 of 2-naphthol, and the π–π stacking between the two coupling partners could play vital roles in the enantiocontrol of this cross-coupling reaction.

THIADIAZOLE DERIVATIVES AS ANTIDIABETIC AGENTS

-

Page/Page column 25-26, (2009/01/24)

Novel compounds that are inhibitors of protein tyrosine phosphatases (PTPases) and, thus, may be employed for the treatment of conditions mediated by PTPase activity. The compounds of the present invention may also be employed as inhibitors of other enzym

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 1092455-29-2